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Dyskerin is an essential, conserved, multifunctional protein found in the
nucleolus, whose loss of function causes the rare genetic diseases X-linked
dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. To further
investigate the wide range of dyskerin’s biological roles, we set up stable
cell lines able to trigger inducible protein knockdown and allow a detailed
analysis of the cascade of events occurring within a short time frame. We
report that dyskerin depletion quickly induces cytoskeleton remodeling and
significant alterations in endocytic Ras-related protein Rab-5A/Rab11 traf-
ficking. These effects arise in different cell lines well before the onset of
telomere shortening, which is widely considered the main cause of dys-
kerin-related diseases. Given that vesicular trafficking affects many homeo-
static and differentiative processes, these findings add novel insights into
the molecular mechanisms underlining the pleiotropic manifestation of the
dyskerin loss-of-function phenotype.
Vesicular transport is a fundamental way of communi-
cation between the cell and its microenvironment and
regulates many vital cellular processes, including inter-
nalization of several types of molecules, nutrients
uptake, membrane protein turnover, cell adhesion or
migration properties, and receptor signaling [1]. A
variety of molecules shuttle in and out of cells via the
endocytic/exocytic pathways. Along the endocytic
pathway, the cargo is internalized by either clathrin-
dependent or clathrin-independent pathways and then
routed to sorting endosomes, to be subsequently
addressed to lysosomes for degradation, or returned
back to membrane via either the fast or the late-recy-
cling routes. The Ras-related in brain (Rab) small G
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proteins are master regulators of vesicular trafficking
[2,3]. In particular, Ras-related protein Rab-5A
(Rab5)-Rab4 sorting endosomes have a key role in
mediating the fast recycling to membrane, while
Rab11 endosomes mediate the slow recycling, moving
from the endocytic recycling compartment (ERC),
localized near the centrosomal microtubule-organizing
center (MTOC), to the cell surface [4,5]. Dysregulation
of vesicle trafficking can underlie diverse aspects of
cancer cell biology, including loss of cell polarity,
transformation, invasion, and metastasis, so that
aberrant expression/regulation of Rab guanosine
triphosphate hydrolase (GTPases), including Rab5 [6]
and Rab11 [7], has been associated with tumorigenesis
[8].
Here, we report that the ubiquitous nucleolar pro-
tein dyskerin, a component of the small nucleolar
ribonucleoprotein complexes (snoRNPs), plays an
unexpected role in the regulation of vesicle trafficking.
Dyskerin, encoded by the human DKC1 gene, is a
multifunctional highly conserved protein that partici-
pates in diverse nuclear ribonucleoprotein complexes,
such as those of active telomerase, type H/ACA
snoRNPs, and small Cajal ribonucleoproteins [9]. All
these complexes are involved in a variety of crucial
biological functions that include safeguarding telomere
integrity, ribosome biogenesis, and pseudouridylation
of cellular RNAs [10–12]. In addition, dyskerin has
been shown to act as a cotranscriptional factor of key
pluripotency-related genes in mammalian embryonic
stem cells [13]. Considering the variety of these biologi-
cal functions, it is not surprising that DKC1 hypomor-
phic mutations cause hereditary disorders, respectively,
known as X-linked dyskeratosis congenita (X-DC) and
Hoyeraal-Hreidarsson (HH) syndrome [14]. Main
manifestation of these diseases is a triad of mucocuta-
neous features accompanied by chronic bone marrow
failure, telomere instability, premature aging, and
increased susceptibility to various types of cancers
[15,16]. Although many authors consider X-DC and
HH mainly as telomeropathies, a wide bulk of data
support the alternative view that the primary cause of
these diseases can be associated with telomerase-inde-
pendent roles of dyskerin. For example, DKC1m mice
show symptoms of the disease before a telomere short-
ening is detectable [15]. Similarly, in an X-DC zebra-
fish model, changes in telomerase activity were
undetectable at early stages, supporting the view that
telomerase deficiency is not responsible for the onset
of X-DC pathogenesis [17]. In addition, although Dro-
sophila lacks a canonical telomerase, Drosophila dys-
kerin is essential for fly viability and its depletion
causes a large variety of developmental defects [18–21].
Finally, snoRNPs have recently gained an important
role in several pathologies, including cancer [22,23].
To investigate in more detail the primary effects
triggered by dyskerin loss-of-function phenotype, we
generated colon carcinoma (RKO) and osteosarcoma
(U2OS) stable cell lines expressing a short hairpin
RNA (shRNA) able to trigger inducible silencing of
the DKC1 gene. These cellular systems enabled us to
analyze in detail the cascade of events occurring within
a short time frame (1–3 cell doublings) immediately
following dyskerin knockdown, and thus largely pre-
ceding the time needed for telomere shortening. With
this approach, we found that dyskerin downregulation
quickly causes cytoskeletal remodeling and dysregula-
tion of Rab5-Rab11 vesicular trafficking, thus reveal-
ing additional and unexpected mechanisms by which
this protein can affect cell homeostasis.
Materials and methods
Construction of the inducible pLKO-Tet-On-
shDKC1 silencing vector
To insert sequences encoding DKC1 shRNA, the pLKO-Tet-
On plasmid (Novagen, Cambridge, MA, USA) was digested
with AgeI and EcoRI enzymes (Promega, Madison, WI,
USA) and then annealed and ligated with two partially over-
lapping oligonucleotides targeting the junction of DKC1 12–
13 exons. Oligonucleotide sequences carrying AgeI and
EcoRI sites at their ends were as follows: forward, 50 CC
GGTATGTTGACTACAGTGAGTCTCTCGAGAGACT-
CACTGTAGTCAACATATTTTT 30; reverse, 50AATTA
AAAATATGTTGACTACAGTGAGTCTCTCGAGAGA
CTCACTGTAGTCAACATA 30 (Sigma-Aldrich, St. Louis,
MO, USA). Competent Stbl4 Escherichia cells (Invitrogen,
Carlsbad, CA, USA) were transformed with ligation prod-
ucts, and plasmid DNA from positive clones were sequenced
to confirm the identity of the shDKC1 silencing construct,
hereafter named pLKO-Tet-On-shDKC1.
Cell culture and generation of shRNA-expressing
stable cell lines
RKO and U2OS human cell lines were obtained from
ATCC (Manassas, VA, USA) and cultured as previously
described [24]. To generate stable cell lines, cells were trans-
fected with 3 lg pLKO-Tet-On-shDKC1 and 12 lL of
Metafectene Pro (Biontex Laboratories GmbH, M€unchen,
Germany), following the manufacturer’s instructions. After
20 days of puromycin selection (750 ngmL1; Sigma-
Aldrich), independent clones were collected and maintained
in media supplemented with Tet-free FBS (Clontech
Laboratories Inc, Mountain View, CA, USA) and puromy-
cin. In the absence of tetracycline (Tet), or its synthetic
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derivative doxycycline (Dox), shRNADKC1 expression is
repressed by the binding of the constitutively expressed
TetR protein to the Tet-responsive element; Tet/Dox addi-
tion (400 ngmL1) to the medium triggers shRNA expres-
sion, resulting in targeted DKC1 silencing [25].
Cell proliferation assays and cytoskeletal analyses
To measure cell vitality and proliferation, an equal number
of RKO Dox-treated and untreated cells (3 9 105/dish)
were seeded in triplicate in 100-mm plates, harvested every
24 h up to 4 days, stained with 0.5% trypan blue
(Euroclone spa, Milan, Italy), and counted by a Burker
chamber. For 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assay, Dox-treated and untreated
cells were seeded in triplicate at the density of 5 9 103 cells
per well in 96-well plates. The day after, culture medium
was aspirated and, after a washing in PBS, replaced with
100 lL of 0.5 mgmL1 MTT solution per well. After 4-h
incubation at 37 °C in 5% CO2 incubator, the medium was
removed and the precipitated formazan was dissolved in
100 lL of acidic isopropanol. The absorbance was quanti-
fied by spectrophotometry at 570 nm using the microplate
reader Victor3 Multilabel Counter (Perkin Elmer,
Waltham, MA, USA).
To trigger cytoskeletal disruption, cells were incubated in
medium containing 3 lM methyl [5-(2-thienylcarbonyl)-1H-
benzimidazol-2-yl] (nocodazole; Sigma-Aldrich) or 3 lM
latrunculin A (Sigma-Aldrich) for 2 h at 37 °C and subse-
quently analyzed by confocal immunofluorescence micro-
scopy (see below).
FACS analysis
Control and Dox-treated cells were trypsinized at the indi-
cated time, counted, washed three times in PBS, and fixed
in ice-cold methanol at 20 °C overnight. Cells were then
washed twice with cold PBS, counted, and rehydrated at
the density of 106 cellsmL1 by incubation in PBS for
30 min on ice. Subsequently, cells were suspended in hypo-
tonic solution 0.1% Na-citrate, 50 lgmL1 RNase,
50 lgmL1 propidium iodide and incubated for 30 min in
the dark at room temperature. The DNA content was mea-
sured using a fluorescence-activated cell sorting (FACS)
Calibur flow cytometer (Becton Dickinson, Franklin Lakes,
NJ, USA), and data were analyzed using the CELL QUEST
PRO and MODFIT3.0 software packages (Becton Dickinson).
RNA and protein analysis
Total RNA extraction, preparation of first-strand cDNA,
and quantitative real-time reverse transcription (qRT)-PCR
were carried out as previously described [26] Oligonucleotide
sequences were as follows: DKC1-F 50-GGCGGATGCG
GAAGTAAT-30, DKC1-R 50-CCACTGAGACGTGTCCA
ACTT-30, glutathione synthetase-F (GSS-F) 50-GGACTGG
CCCTGGGAATT-30, GSS-R 50-CCTTCTCTTGAGCAA
TCAGTAGCA-30. Western blot analysis was conducted
according to [27]. Used antibodies are reported in Table S1.
WGA and transferrin uptake assays,
immunofluorescence analysis
For wheat germ agglutinin (WGA) live staining, cells were
incubated at room temperature for 10 min with WGA/
Texas red conjugate (W21405; Thermo Fisher Scientific,
Waltham, MA, USA) and fixed with 3.7% paraformalde-
hyde for 10 min. For confocal immunofluorescence analy-
sis, RKO- and U2OS-transfected cells were preliminarily
seeded on glass coverslips in six-well plates and treated for
72 h with Dox. Dox-treated or untreated cells were then
fixed with 3.7% paraformaldehyde for 10 min, permeabi-
lized in 0.3% Triton X-100 for 15 min, and blocked in PBS
supplemented with 3% BSA for 30 min. After each step,
the cells were rinsed in PBS, incubated for 1 h at room
temperature with primary antibodies and then for 30 min
at room temperature with secondary antibodies (listed in
Table S1). Uptake assay of Alexa Fluor 488-conjugated
transferrin (T13342; Thermo Fisher Scientific) was con-
ducted according to [28]. Upon indicated treatments, cover-
slips were mounted on glass slides with Hoechst solutions
and examined under the fluorescence confocal microscope
Zeiss LSM 700 (Zeiss, Oberkochen, Germany).
Results
Generation and validation of stable cellular
systems for DKC1-inducible knockdown
To perform a careful analysis of the early events trig-
gered by dyskerin depletion, we generated an inducible
DKC1 silencing lentiviral vector that contained all the
necessary components to express DKC1 shRNA upon
Tet/Dox addition (see Materials and methods). The
silencing efficiency of the vector, named pLKO-Tet-
On-shDKC1, was first tested in the RKO human colon
cancer cells that are diploid, poorly differentiated, and
express wild-type p53, APC, and b-catenin [29]. Inde-
pendent stable clones were isolated and DKC1 knock-
down evaluated at both mRNA and protein levels. As
shown in Fig. 1A, the system was quickly responsive,
as dyskerin amount was significantly reduced after
only 24 h from Dox induction and further decreased
subsequently. In strict agreement, reverse qPCR exper-
iments showed a parallel downregulation of dyskerin
mRNA levels. Confocal microscopic analysis con-
firmed a strong reduction in dyskerin accumulation in
the nucleoli of the silenced cells (Fig. 1B), further vali-
dating the silencing efficiency. Moreover, the silencing
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conditions did not perturb the nucleolar accumulation
of fibrillarin, a highly conserved nucleolar protein
associated with box C/D small nucleolar RNAs (snoR-
NAs) [30], leading to rule out the occurrence of obvi-
ous nucleolar alterations (Fig. 1B). Altogether, these
observations showed that this inducible system was
able to generate stable cellular clones useful to define
the early consequences of dyskerin depletion. A set of
different approaches was then performed and followed
on independent clones. First, we checked the effects of
DKC1 gene silencing on cell proliferation. Dyskerin
depletion has in fact generally been reported to per-
turb this parameter [31,32], although the specific phase
of the cell cycle at which cells accumulate diverged
among different cell types. Consistent with previous
findings, both a direct count of viable cells and MTT
measurements indicated that cell proliferation progres-
sively decreased upon Dox-induced DKC1 silencing
(Fig. 1C). We confirmed that the decrease in cell num-
ber was not due to apoptosis, as poly (ADP-ribose)
polymerase-1 (PARP-1) and caspase 3, two known
apoptotic markers, were not activated upon gene
silencing. Both markers were instead efficiently cleaved
upon treatment with the proapoptotic topoisomerase
II inhibitor doxorubicin (Dxr), thereby providing a
positive control (Fig. 1D). FACS analysis revealed an
Fig. 1. Validation of Dox-inducible DKC1 silencing and its effects on proliferation of RKO cells. (A) Time-course analysis of DKC1
expression upon Dox-induced silencing: on the left, immunoblotting analysis of dyskerin levels; on the right, qRT-PCR analysis of dyskerin
mRNA accumulation. (B) Confocal microscopic images of control (Dox) and silenced (Dox+) RKO cells confirming the efficacy of
dyskerin depletion and the appropriate nucleolar localization of fibrillarin. The sum of total z-stack focal planes is shown. (C) On the left,
growth curves of control (Dox) and silenced cells (Dox+); on the right, MTT assay: a two-way ANOVA test was performed, with
**P < 0.005. For both experiments, each point represents the mean  SEM of three different experiments. (D) No activation of the
PARP1 and caspase-3 apoptotic markers was observed in dyskerin-depleted (Dox+) cells, while both markers were induced upon Dxr
treatment (Dxr+), used as positive control (first lane). These results indicate that the reduction in cell number was not due to apoptosis.
(E) FACS analysis indicates that dyskerin-depleted cells (Dox+) are delayed at G1/S progression compared to their control (Dox). (F)
Western blot analysis displayed an increase in p21 expression in the silenced cells, confirming that G1/S progression is halted (in
agreement with FACS results).
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increase in the G1 percentage of the silenced cells
(42.4% compared to 33, 5% of control cells; Fig. 1E),
accompanied by a slight reduction in the S-phase
(42.8% compared to 46.9% of the control cells) and
G2-phase percentages (14.4% compared to 17.4% of
control cells). Dyskerin depletion was reported to
induce a block at G1 also in yeast [33] and, more
recently, in neuroblastoma cells [34]; in this latter case,
the proliferative arrest was observed to be unrelated to
human telomerase RNA levels or to telomerase activ-
ity [34,35]. To further investigate the effect of dyskerin
depletion on cell cycle, we checked the expression of
p21, a protein that plays a key role in G1/S cell cycle
arrest [36]. In keeping with FACS results, p21 accumu-
lation raised significantly upon dyskerin depletion
(Fig. 1F), confirming that G1/S progression was
halted. Noticeably, this effect occurred very early upon
dyskerin knockdown and thus had no correlation with
telomere instability.
Dyskerin depletion affects Rab5- and Rab11-
mediated recycling
Morphological analysis of RKO-silenced cells showed
that only 24 h from silencing induction they lost the
typical epithelia-like structure and tended to assume a
round-shaped morphology and appeared highly refrac-
tile when observed by phase-contrast microscopy
(Fig. 2A). In addition, about 10% of these cells
detached from the plate. However, when recruited
from the medium, they remained unstained by the try-
pan blue dye and, after transferring in a Dox-free
medium, recovered their substratum-adhesive property
(data not shown). These observations suggested that
this feature was reversible and dependent on DKC1
gene activity, and highlighted that dyskerin depletion
can promote a cytoskeletal remodeling resulting in a
quick transition from an adherent state to a suspended
one. Thus, we first analyzed the microtubule and actin
networks by immunofluorescence staining of b-tubulin
and F-actin. Indeed, analysis of confocal images indi-
cated that, upon dyskerin depletion, RKO cells are
characterized by reduced anti-b-tubulin immunoreac-
tivity and presence of less stretched and oriented
microtubule filaments. In addition, phalloidin staining
revealed that the actin meshwork appeared thinner
and displayed a reduced number of filopodia in the
silenced cells (Fig. 2B). These observations fully sup-
port the view that cytoskeletal scaffolding undergone a
prompt rearrangement. As microtubules and actin fila-
ments, together with motor proteins, support vesicles
movements [1], we wondered whether cytoskeletal
remodeling had any impact on vesicular trafficking. To
gain information on this latter aspect, we firstly
followed the in vivo internalization of Texas
red-conjugated WGA, a carbohydrate-binding lectin
that recognizes sialic acid and N-acetylglucosaminyl
sugar residues on the plasma membrane. WGA is
widely used to follow receptor-mediated membrane
transport and vesicular trafficking; its uptake is an
active, energy-dependent process mediated by both
actin filaments and microtubules [37]. As shown in
Fig. 3A, WGA staining marked more heavily both the
peripheral membrane and the internal vesicles of dys-
kerin-depleted cells, suggesting an increase in the
receptor-mediated endocytic process. To further
explore this feature, we analyzed by confocal micro-
scopy the distribution of vesicles positive for Rab5, a
small GTPase that marks the early Rab4-Rab5 endo-
somes and mediates the fast recycling to membrane
[2]. Indeed, Rab5 staining incremented significantly in
the silenced cells (Fig. 3A), supporting the conclusion
that dyskerin depletion can enhance endocytosis and
the fast recycling route. To check the slow recycling of
endocytosed proteins, by which the cargo traverses the
endosomal recycling compartment (ERC) and is
addressed back to cell periphery, we looked at the
Rab11 late-recycling endosomes [5]. Confocal micro-
scopic analysis of distribution of Rab11 vesicles
showed that in the control cells they mainly concen-
trated at ERC and at cortical periphery, where they
are particularly enriched at cell–cell contacts (Fig. 3A).
In contrast, in dyskerin-depleted cells, the density of
Rab11 endosomes appeared drastically reduced, with
these vesicles essentially clustered at pericentrosomal
ERC, poorly diffused throughout the cytoplasm, and
nearly absent at cell periphery (Fig. 3A). The loss of
Rab11 cortical localization indicated that the slow
recycling to membrane was drastically hampered in the
silenced cells, implying a possible dysregulation of this
important process [38]. Worth noting, western blot
analyses confirmed that Rab5 and Ras-related protein
Rab-11A (Rab11A) expression levels are differentially
influenced by dyskerin depletion (Fig. 3B,C). As
Rab11 vesicles play a regulatory role also in the exo-
cytic process, modulating the transport of secretory
vesicles to the plasma membrane [39], we labeled cells
with CD63, a marker of both late endosomes lyso-
somes and exocytic multivesicular bodies (MVBs) [40].
However, no significant alteration in the density/distri-
bution of CD63 vesicles, or in their mobilization
toward cell periphery, was observed (Fig. 3A), suggest-
ing that dyskerin depletion specifically affected the
dynamics of Rab11-mediated transport from ERC to
the membrane. To ensure that Dox treatment could
not elicit, by itself, any of the above-described effects,
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we treated RKO-untransfected cells with 400 ngmL1
Dox for 72 h. As shown in Fig. S1, Dox treatment
per se did not induce changes in cell shape, cytoskele-
tal remodeling, or alteration in density/localization of
Rab5/Rab11 endosomes, confirming the specificity of
the observed phenotypes.
Rab11 mislocalization in dyskerin-depleted cells
is not due to the disruption of cytoskeletal
scaffolding
To rule out the possibility that Rab11 mislocalization
could be due to cytoskeletal damages eventually
caused by dyskerin depletion, we pretreated cells with
nocodazole or latrunculin A, two cytoskeletal disrup-
tive drugs, and then looked at the intracellular distri-
bution of Rab11 endosomes. Treatment either with
nocodazole, which rapidly depolymerizes microtubules
and MTOC [41], or with latrunculin A, which depoly-
merizes F-actin [42,43], completely dispersed Rab11
vesicles from the pericentrosomal region, promoting
their cytosolic diffusion in both control and silenced
cells (Fig. 4). Cytosolic dispersion appeared more pro-
nounced upon latrunculin treatment, suggesting that in
RKO cells the Rab11 vesicles might travel preferen-
tially along actin network. Anyhow, none of these
treatments mimicked the Rab11 mislocalization
observed upon dyskerin depletion. On the contrary,
both drugs counteracted the accumulation of Rab11
vesicles at ERC, ruling out the possibility that this
specific phenotype could be attributed to disruption of
the cytoskeletal scaffolding. Collectively, the above
results lead to conclude that dyskerin depletion can
induce alterations in cell shape, cytoskeletal scaffold-
ing, and vesicular trafficking within only 72 h from
silencing induction. As none of these effects occurred
upon Dox exposure of untransfected RKO control
cells (Fig. S1), it is reasonable to conclude that they
are specifically triggered by dyskerin depletion.
Cytoskeletal remodeling and alteration of
vesicular trafficking are telomerase-independent
effects of dyskerin depletion
To exclude cell line-specific effects and to firmly assess
that the above-described effects were independent from
telomere instability, we extended our analyses to the
human osteosarcoma epithelial (U2OS) cell line. U2OS
cells were selected because, although telomerase-nega-
tive [32], they elongate telomeres efficiently by the
alternative lengthening of telomeres (ALT) pathway
[44]. As shown in Fig. 5, the pLKO-Tet-On-shDKC1
vector caused a very efficient dyskerin downregulation
also in U2OS cells, confirming its general applicability.
Remarkably, dyskerin depletion was again accompa-
nied by an abrupt change in cell morphology, with
U2OS-silenced cells quickly assuming a more stretched
shape (Fig. 5). Next, we checked the distribution of
Rab5 and Rab11 endosomes. As shown in Fig. 6,
Rab5 trafficking significantly increased upon dyskerin
depletion, confirming the tendency to a more active
endocytosis and to a fast recycling. The intracellular
distribution of Rab11 slow-recycling endosomes was
also significantly altered, being even more evident in
these cells because of their large size. In fact, in the
control cells, the Rab11 vesicles heavily marked both
ERC and cell periphery and were amply dispersed
throughout the cytosol, where they closely matched
the microtubule network (Fig. 6). In contrast, upon
dyskerin depletion, the density of these late endosomes
was strongly reduced and they appear predominantly
clustered at ERC, poorly dispersed in the cytosol, and
dramatically reduced at the cortical region (Fig. 6). To
functionally analyze the endocytic and recycling pro-
cesses, we next followed the internalization of transfer-
rin. This protein is internalized by a receptor-mediated
process [45] and is recycled through the ERC by
Rab11 vesicles [46]. In these experiments, we incubated
control and silenced cells with a 15-min pulse of Alexa
Fluor 488-conjugated transferrin at 4 °C, followed by
a chase of 15 and 60 min at 37 °C. As shown in
Fig. 7, transferrin was very efficiently internalized also
in dyskerin-depleted cells where, immediately following
its uptake (15-min chase), assumed an intracellular dis-
tribution very similar to that observed in the control
cells. In fact, in both silenced and control cells, trans-
ferrin did not colocalize with Rab11 at these early
times. However, upon 60 min of chase, in the control
cells a large amount of transferrin colocalized with
Rab11 vesicles (Pearson’s coefficient 0.8), which
appeared amply dispersed throughout the cytoplasm.
Conversely, in the silenced cells, transferrin and Rab11
Fig. 2. Dyskerin-depleted RKO cells exhibit morphological changes and cytoskeletal rearrangement. (A) Phase-contrast imaging of control
(Dox) and silenced cells, the latter treated with Dox for 72 h (Dox+). Note that, upon Dox induction, the cells tend to assume a round-
shaped morphology (see black arrows). (B) Confocal analysis of control (Dox) and silenced cells (Dox+) upon costaining with b-tubulin
(green) and dyskerin (gray) antibodies and phalloidin (red). Nuclei were counterstained with 40-6-diamidino-2-phenylindole (DAPI; blue). The
sum of five z-stack central focal planes is shown.
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signals colocalized essentially only at the ERC (Fig. 7),
confirming the occurrence of a defective late recycling.
Hence, the results of this functional assay further
supported the conclusion that alteration of Rab11
receptor-mediated recycling occurs in diverse cell lines
as a precocious effect of dyskerin depletion.
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Discussion
To deeply investigate the range of dyskerin biological
roles, we set up cellular systems able to trigger
inducible DKC1 gene silencing and allow a detailed,
short-term analysis of the events immediately following
protein knockdown. Here, we report that dyskerin
suppression shortly induces a cytoskeletal remodeling
which triggers changes in cell shape well before the
eventual occurrence of telomere erosion. Specifically,
the cytoskeletal rearrangements induced by dyskerin
depletion weakened cell adhesion to substrate in both
RKO and U2OS cells, although this effect was less
intense in the U2OS line, whose cells have thicker
stress fibers and more robust focal adhesion complexes
[47]. Noticeably, dyskerin downregulation was found
to induce loss of cell–substratum adhesion also in
prostate carcinoma [31] and in neuroblastoma cells
[32], although this aspect has remained so far poorly
investigated. Indeed, it is reasonable to suppose that
anchorage weakening can be a general feature that
contributes to growth and proliferative impairment
that characterizes various cell types upon dyskerin
depletion. The reshuffling of the cytoskeleton is linked
to many dynamic cellular processes, such as cell divi-
sion, motility, endocytosis, and vesicular trafficking.
Here, we focused our analysis on the intracellular
transport, mainly with respect to endocytic and recy-
cling processes. We found that the fast endocytic recy-
cling was incremented in the silenced cells, possibly
accelerating the return of specific cargos to membrane.
At the same time, a dramatic reduction in Rab11 late-
recycling endosomes was observed, with these vesicles
essentially clustered at the pericentrosomal ERC and
nearly absent at cell cortex. Traveling of Rab11 vesi-
cles from ERC to cortex requires interaction with a
number of effectors, including the Rab11 family-inter-
acting proteins (FIPs), which mediate association with
microtubule- or actin-based molecular motors and
enable both movement and correct intracellular posi-
tioning of these vesicles [4]. The most obvious explana-
tion for Rab11 accumulation at the ERC may thus
rely on a transport defect. However, this phenotype
has similarly been observed upon depletion of the
Rab11 GAP Evi5 [48], suggesting that also deregulated
Rab11 activation can favor trapping of these vesicles
at the ERC, strongly reducing Rab11-dependent, slow
recycling. This finding further highlights the complex-
ity of dyskerin cellular functions, although the specific
mechanisms by which this protein can influence
cytoskeletal and vesicular dynamics remain elusive.
Indeed, several telomerase-independent roles of dys-
kerin may be involved. Dyskerin, by associating with
other core proteins and H/ACA snoRNAs, can in fact
participate in diverse ribonucleoprotein complexes
involved in rRNA processing and site-specific pseu-
douridylation of rRNA, snRNAs, as well as of
mRNAs [49]. In turn, reduction in rRNA pseu-
douridylation affects ribosome translation fidelity [50]
and internal ribosome entry site-dependent translation
efficiency [51]. Thus, it is conceivable that these func-
tions could contribute to cytoskeletal rearrangement
and alteration of vesicular trafficking. For example,
dyskerin depletion may deregulate the expression of
mRNAs involved in these processes, or affect these cel-
lular dynamics in association with specific H/ACA
snoRNAs. Intriguingly, this hypothesis is favored by
recent studies that established an emerging role of
snoRNAs in specific metabolic functions. A striking
example is that of U17, a dyskerin binding snoRNA
involved in intracellular cholesterol trafficking [52].
Worth noting, proper sorting and trafficking within
endosomal vesicles is necessary to maintain cellular
homeostasis and to perform both ubiquitous and cell
type-specific functions. In fact, perturbation of this
traffic widely affects cargo destination and membrane
properties, this way potentially altering cell–cell and
cell–extracellular matrix interactive communication
and related differentiative events. Consistent with these
premises, dyskerin depletion may cause both cell-
autonomous and nonautonomous effects, as observed
for developmental defects and alterations of long-range
signaling occurring in Drosophila upon in vivo silenc-
ing of the DKC1 orthologue [19–21]. Finally, the endo-
cytic pathway intersects other intracellular transport
routes, such as the secretory pathway and the retro-
grade transport of selected cargo from ERC to the
Fig. 3. Dyskerin-depleted RKO cells show enhanced endocytosis. (A) Confocal analysis of control (Dox) and silenced cells (Dox+) upon
WGA uptake in vivo (top), or upon staining with Rab5, Rab11A or CD63 (bottom) antibodies. Images of control and silenced cells were
acquired at the same conditions. For WGA and Rab11A analysis, the image shows the sum of z-stack total focal planes; for Rab5 and CD63
analysis, images show the sum of five z-stack central focal planes; nuclei were counterstained with 40-6-diamidino-2-phenylindole (DAPI).
Note that an increase in WGA active uptake and Rab5-mediated vesiculation characterize dyskerin-depleted cells, while no significant
alteration in the distribution of CD63 vesicles is observed. (B) Immunoblotting time-course analysis of Rab5 expression upon Dox-induced
dyskerin silencing and relative densitometric quantitative analysis. (C) Immunoblotting time-course analysis of Rab11A expression upon Dox-
induced dyskerin silencing and relative densitometric quantitative analysis.
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Fig. 4. Dyskerin-depleted RKO cells are characterized by reduced density and mislocalization of Rab11 vesicles. Confocal images of control
(Dox) and silenced cells (Dox+), untreated () or treated (+) with nocodazole (top) or latrunculin A (bottom). Cells were costained with
Rab11A (green) and b-tubulin (red) antibodies or with Rab11A antibody (green) and phalloidin (red). Nuclei were counterstained with 40-6-
diamidino-2-phenylindole (DAPI; blue). All signals are shown in gray in the left insets. Images of control and silenced cells were acquired at
the same conditions; the sum of five z-stack central focal planes is shown. Note that silenced cells are characterized by a dramatic
reduction in Rab11A labeling at cell periphery, accompanied by a pericentrosomal accumulation at the ERC; this phenotype is not mimicked
by cytoskeletal disruptions induced by either nocodazole or latrunculin A treatment, as both of them promote diffusion of Rab11 vesicles.
Fig. 5. Morphological changes and cytoskeletal rearrangements upon DKC1 silencing in the telomerase-negative U2OS cells. (A) Western
blot (left) and confocal immunofluorescence analysis (right) confirmed the efficient dyskerin downregulation upon 72 h of Dox induction. (B)
Confocal analysis of U2OS control (Dox) and silenced cells (Dox+) stained with DyLight 550 phalloidin; nuclei were counterstained by 40-6-
diamidino-2-phenylindole (DAPI; blue). Images of control and silenced cells were captured under the same conditions; a z-stack central focal
plane is shown. As observed in the RKO line, upon dyskerin depletion U2OS cells exhibit morphological changes, assuming a more
extended shape.
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Fig. 6. Dynamics of endosomal trafficking in U2OS dyskerin-depleted cells. Confocal images of control (Dox) and silenced cells (Dox+)
costained with Rab5 (green) and b-tubulin (red) antibodies (top); Rab11A (green) and b-tubulin (red) antibodies (middle); dyskerin (green) and
CD63 (magenta) antibodies (bottom). All signals are in gray in the left insets; nuclei were counterstained with 40-6-diamidino-2-phenylindole
(DAPI; blue). Images of control and silenced cells were captured under the same conditions; the sum of z-stack five central focal planes is
shown. As in RKO cells, dyskerin depletion enhances Rab5 trafficking while it hampers Rab11 recycling to membrane; no significant
alteration in the distribution of CD63 vesicles is instead noticed.
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Fig. 7. Transferrin uptake and its distribution in dyskerin-depleted U2OS cells. Control (Dox) and silenced (Dox+) U2OS cells were pulsed
with Alexa Fluor-488-conjugated transferrin at 4 °C for 15 min (top), then chased at 37 °C for 15 or 60 min and stained with Rab11A
antibody (red). Nuclei were counterstained with 40-6-diamidino-2-phenylindole (DAPI; blue). A z-stack central focal plane is shown. In both
control and silenced cells, transferrin is efficiently internalized, as evident upon 15-min chase (middle). However, upon 60-min chase,
transferrin colocalizes diffusely with the Rab11 vesicles, amply dispersed in the cytoplasm only in the control cells. Transferrin–Rab11A
colocalization is scarce and restricted to some ERC regions in the dyskerin-depleted cells (bottom).
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trans-Golgi network (TGN). While the relationship
with the TGN pathway remains to be investigated, the
unaltered intracellular distribution of CD63 exocytic
vesicles suggests that their specific trafficking is not
affected. Collectively, our results indicate that DKC1
silencing can perturb several aspects of cell homeosta-
sis independently of telomere instability. The observa-
tion that dyskerin can orchestrate vesicular traffic not
only adds further information on the multiple biologi-
cal roles played by this protein but gives novel insights
into the comprehension of molecular mechanisms
underlying the congenital diseases triggered by dys-
kerin depletion.
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